Organization
Pluristem Therapeutics Inc.
Topic
All Topics
People
Find news about people
Alumni
Find news on alumni of any org
Industries
Find news on a particular market
Your Contacts
Find news on your contacts
Sign up for free daily alerts on this feed:
By pressing Sign Up, you agree to our Terms of Use, Privacy Policy, and the LexisNexis Terms & Conditions

Follow

Change Feed

News on Pluristem Therapeutics Inc.

... held in November HAIFA, Israel, Oct. 18, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell ...
... Pluristem enters into agreement with WideTrial Inc. to conduct the programWideTrial will purchase ...
... performance and workflow efficiency. The findings confirmed that the latest artificial intelligence (AI) software solution to support DBT increased improvements in both reader sensitivity (8.0 ...
... the market. The company is reportedly working on a phone that uses AI to mimic the user and automatically respond to messages for them, according ...
... the United Kingdom HAIFA, Israel, Oct. 10, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell ...
... has partnered with UK-based medical firm Medopad to develop an artificial intelligence (AI) system for remote monitoring of patients suffering from Parkinson's disease. The partners ...
... into a discipline that is quantitative, predictive, and patient-centric via big data, AI and machine learning. She cofounded two AI and machine learning companies, Gene ...
... is the need for technical knowledge amongst operators. Knowledge of working of AI software platforms is necessary for smooth operations and operational excellence. The lack ...
... and artist, today announces the release of her pop album titledI AM AI. The first ever musical collaboration between a solo artist and artificial intelligence, ...
... HAIFA, Israel, Sept. 27, 2018 (GLOBE NEWSWIRE) -- Pluristem Therapeutics Inc. (Nasdaq:PSTI) (TASE:PSTI), a leading regenerative medicine company developing novel placenta-based cell ...
Subscribe now for full coverage on Pluristem Therapeutics Inc.
Start My Free Trial